"Cymerus technology cracks the biggest problem in stem cell medicine, which is how to make unlimited amounts of mesenchymal stem cells from a single donor.
The advent of Cymerus will transform medical practice. Right now, MSC-based treatments are boutique—very expensive because of the need to continually locate streams of new donors. Our non-donor-dependent method will transform stem cell medicine into an affordable and potent off-the-shelf product. It will not be sold over the counter, but it will be available at the right price as prescribed by a doctor. Our major breakthrough is being able to create uniform batches of MSCs at a reasonable price. Hundreds of millions of people are affected by strokes, heart disease, and Crohn's disease. They will demand this medicine, and we can provide it at good value. "
